I purchased some more ACTC stock on Thursday last week. It dropped by almost $0.02 per share through Monday, August 8, 2011. They had a good conference call that is on its web site (http://www.advancedcell.com/) and hope to have significant value creation if the clinical trials go well.
I will watch the stock price over the next few days and I am considering buy more in August or early September. The company is supposed to provide information about the initial clinical trials in October 2011.
Tuesday, August 9, 2011
Subscribe to:
Posts (Atom)